Advertisement
Advertisement
Ozempic

Ozempic

semaglutide

Manufacturer:

Novo Nordisk A/S
Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.
Core Prescribing Info
Contents
Semaglutide
Indications/Uses
Adults w/ insufficiently controlled type 2 DM as an adjunct to diet & exercise as monotherapy when metformin is considered inappropriate due to intolerance or contraindications & in addition to other medicinal products for the treatment of diabetes.
Dosage/Direction for Use
SC Starting dose: 0.25 mg once wkly, increased to 0.5 mg once wkly after 4 wk. After at least 4 wk w/ 0.5 mg once wkly, can be increased to 1 mg once wkly to further improve glycaemic control.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BJ06 - semaglutide ; Belongs to the class of glucagon-like peptide-1 (GLP-1) analogues. Used in the treatment of diabetes.
Presentation/Packing
Form
Ozempic soln for inj 1.34 mg/mL
Packing/Price
1's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement